Setting: Neuro-Urology, Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland. Objectives: This review considers intravesical treatment options of neurogenic detrusor ...
Activation of muscarinic receptors on the detrusor smooth muscle is followed by contraction, which involves both myosin light chain kinase (MLCK) and Rho kinase (ROCK). The aim of this study was to ...
Elderly woman Medications for storage and voiding symptoms were often prescribed for detrusor underactivity. Detrusor underactivity in older adults appears to gradually worsen over time with no ...
Clinicians managing patients with neurogenic bladder (NGB) and neurogenic detrusor overactivity (NDO) are faced with a myriad of complex choices when deciding on appropriate medical and/or surgical ...
NORTH CHICAGO, Ill., Feb. 10, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved BOTOX® for the treatment of ...
Both formulations are indicated for patients aged 3 years and older; however, the tablet formulation is specifically approved for patients weighing 35kg or more. The Food and Drug Administration (FDA) ...
Neurogenic bladder control is a condition of loss of urinary function due to nerve, spinal cord or brain damage. A variety of circumstances can lead to neurogenic bladder, including spinal injury, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results